您的位置: 首页 > 农业专利 > 详情页

NOVEL CONCEPT TO REDUCE LEFT ATRIAL PRESSURE IN SYSTOLIC AND DIASTOLIC HF PATIENTS TO TREAT PULMONARY EDEMA AND REDUCE HOSPITALIZATION RATES
专利权人:
Boston Scientific Scimed, Inc.;Mayo Foundation for Medical Education and Research
发明人:
Umang Anand,Raghav Goel,Roger W. McGowan,Daniel Ross,Patrick A. Haverkost,Mary M. Byron,David R. Wulfman,James P. Rohl,Peter M. Pollak,Lyle J. Olson,Atta Behfar,Charles J. Bruce
申请号:
US15015298
公开号:
US20160220357A1
申请日:
2016.02.04
申请国别(地区):
US
年份:
2016
代理人:
摘要:
Devices provided herein can include implantable transseptal flow control components adapted to be implanted in an opening in a septal wall. In a closed configuration, the implantable transseptal flow control components provided herein prevent blood from flowing through the opening. In an open configuration, the implantable transseptal flow control components provided herein allow blood to flow from the left atrium to the right atrium. In a closed configuration, implantable transseptal flow control components provided herein can be configured such that blood does not stagnate at a location proximate to a left atrium flow control component side when the pressure differential is below a second predetermined threshold pressure value.Implantable transseptal flow control components provided herein can remain in a closed configuration when a pressure differential between the left atrium and the right atrium is less than a first non-zero predetermined threshold pressure value.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充